Resultaten

…Dignan FLet al. Organ-specific management and supportive care in chronic graft-versus-host disease. Br J Haematol. 2012;158:62-78. Koc S et al. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine…

…Erfelijkheid AD AD AD AR AR AD Respons op DDAVP Meestal goed Vaak matig Contra-indicatie trombocytopenie Initieel goed, maar korte halfwaardetijd Niet Contra-indicatie trombocytopenie vWF:RCF = vWF ristocetine cofactor activiteit…

…Erfelijkheid AD AD AD AR AR AD Respons op DDAVP Meestal goed Vaak matig Contra-indicatie trombocytopenie Initieel goed, maar korte halfwaardetijd Niet Contra-indicatie trombocytopenie vWF:RCF = vWF ristocetine cofactor activiteit…

…in sickle cell disease: clinical presentation and course. Blood 1997; 89: 1787-1792. Vichinsky, E.P. et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle…

…as well as screening of unique patient data sets/biobanks to drive research in a bedside-to-bench and back manner. Our research hinges on a close collaboration between clinical and basic scientists….

…sys rev, 2012. Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis, J of Clin Oncology 2007. ECIL guidelines for antifungal management in leukemia…

…sys rev, 2012. Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis, J of Clin Oncology 2007. ECIL guidelines for antifungal management in leukemia…

…sys rev, 2012. Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis, J of Clin Oncology 2007. ECIL guidelines for antifungal management in leukemia…

Deze print is 24 uur geldig na het aanmaken. Aangemaakt op: 27-9-2024, 5:44